The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

MLYS FINANCIAL STATEMENTS

Mineralys Therapeutics, Inc. Common Stock — balance sheet, income statement and cash flow trends

MLYSMineralys Therapeutics, Inc. Common Stock

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-300 M-200 M-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-34 K $ · -Infinity%Operating Income-370.8 M $ · -Infinity%Pre-tax Income-349.6 M $ · -Infinity%Net Income to Owners-349.6 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-34 K $—
Operating Income-370.8 M $—
EBITDA-349.5 M $—
Net Income to Owners-349.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets667.9 M
  • Equity550.9 M $82%
  • Current Liabilities19.3 M $3%
  • Long-term Liabilities97.6 M $15%

Key Figures

YoY change
Total Assets667.9 M $+98.9%
Total Liabilities116.9 M $+427.4%
Total Equity550.9 M $+75.7%
Cash & ST Investments138.3 M $-57.4%
Total Debt——
Net Debt-138.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-600 M-400 M-200 M0-138.8 M $Operating-484.2 M $Investing659.4 M $Financing36.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-138.8 M $—
Capital Expenditures15 K $-59.5%
Free Cash Flow-138.8 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MLYS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.